A traditional Dai medicinal decoction protects against alcohol-associated liver disease by activating the PPARα–CYP4A14 axis and reprogramming arachidonic acid metabolism, according to a new multi-omics and experimental study.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.